Co-founded “C” corporation to commercialize his patented platform technology that combines ultrasound and light energies to treat bacterial biofilms, with an initial market target of acne. Managed the technical and corporate development of the company, including systems development, testing, and analysis, as well as governance and fundraising. • Independently developed the core IP years prior to founding the company• Authored successful grant applications to the NIH and the Ben Franklin Technology Partners• Designed, constructed, and calibrated the initial prototypes for both in-vitro and in-vivo experimentation• Managed the regulatory approach and interacted with FDA to obtain guidance for future approval strategy• Represented Company to potential investors and the media, via written and verbal communication, raising $2.4MM• Directed and expanded corporate IP portfolio, including continuation, divisional, and overseas filings • Developed business financing model, comprising R&D, clinical, production, regulatory, and Go-to-Market executionCompany has now moved to a licensing mode, with a strong IP portfolio.

Responsible for new product development, applying ultrasound technology to the aesthetic market. Directed product development from a single product offering to multiple lines over a range of market applications, changing the corporate culture and driving growth. Corporate revenues doubled over the course of employment, principally through new products he developed. Sold to Solta in 2013• Reported to the CEO and the Board of Directors, responsible for budgets and corporate business direction• Managed and significantly expanded IP portfolio as well as directing strategic research initiatives• Oversaw complete redesign and relaunch of Company’s flagship product, including expansion of applications• Developed several new product categories in the aesthetic market including first in class ultrasound imaging system and non-invasive ultrasound fat treatment approach• Directly supported product sales, through sales personnel training, lectures and published research, and direct interaction with KOLs, physicians and users

Internationally recognized expert in ultrasonic/acoustic technology, including transducers, systems, acoustic output, biological interactions, and image processing. Consulting expertise in management, product development, research, testing, manufacturing, intellectual property and regulatory. Example projects:• Ultrasonic Surgery - Developed unique instrumentation and methods, some now international standards, others incorporated into new client IP. Considered the leading authority on acoustics of ultrasonic surgery. • Ultrasonic systems for blood clot disruption – Consulting CTO role, moved the company to metrics-based design approach, presented technology to physicians and Marketing Staff.• Ultrasound for wound healing – Conducted FDA presentations, competitive analysis, and developed optimal treatment strategies • Ultrasound for ischemic stroke treatment –Developed the first prototype of a multi-channel system means to assure consistent energy delivery. • Transesophageal system for cardiac output measurement – Redesigned transducer, established new production metrics, directly supervised clinical trials, and developed new software detection algorithms for more consistent results. • Wrist-watch ultrasound for pulse monitoring – Rescued company’s FDA strategy • Ultrasonic toothbrush – Reduced manufacturing variability from 120% to 15%, with <20 cents added cost. Set up new processes at plant in China.• Ultrasonic cosmetic device – Managed redesign of both electronics and transducer assembly. Established new procedures in Taiwan, reduced product variability by 5x.• Ultrasonic brain stimulation system – Lead technical role, converted lab curiosity into viable product. Developed new IP, set up manufacturing chain within QMS structure.• Expert witness – IP, trade, and medical injury litigation, including investigation, report preparation, deposition and testimony in both bench and jury trials. Examples: General Electric v. Sonosite, Ethicon v. Covidien.

Perceptron purchased my company in 1998 and I continued to run it as a group within Perceptron's Forest Products Division. I was responsible for developing new ultrasound applications in the wood and forest products industries, with a engineering staff of 20.Responsible for the research, design, development and sales of ultrasound systems applied to the Forest Products Industry. Managed R&D team bringing new product concepts to market, including extensive personal research, from computer simulation to field installation. Extensive technology transfer experience with government and university laboratories.

Formed company specializing in FDA measurement of medical ultrasound devices; managed company's growth and technical capabilities to become one of the leading independent ultrasonic laboratories. Supervised company’s expansion into non-medical ultrasonic product development. Conceived, designed, and managed new product entries in the livestock and wood industries. Personally consulted on: transducer design, testing, and quality control; phacoemulsification probes; lithotripters; catheter systems; nebulizers; ultrasound applications in process control, forestry industries; regulatory requirements for ultrasound and lithotripsy systems. Managed sale of company to Perceptron in 1998.